ConductScience.org, home

Paper1980339

Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.

Klein E and 2 others. Mol Immunol, 1990. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. Papers, record 1980339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1980339

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.
PubMed
Journal
Mol Immunol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2019-08-24
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klein EE
2Di Renzo LL
3Yefenof EE

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C3bMajor topic
Cytotoxicity, ImmunologicMajor topic
Killer Cells, NaturalMajor topic
Lymphocyte Function-Associated Antigen-1Major topic
Receptors, ComplementMajor topic
Antigens, CD
CD18 Antigens
Humans
Macrophage-1 Antigen
Receptors, Complement 3b
Receptors, Leukocyte-Adhesion

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2RO1 CA25250-10NCI NIH HHSUnited StatesRO1CA252501PubMedNIH RePORTER
R01CA025250NIHNIH RePORTER

Download CSV of grants

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
40904461The complement system in human pregnancy and preeclampsia.Front Immunol2025https://conductscience.org/library/papers/40904461PubMed
35197461Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.Nat Commun2022https://conductscience.org/library/papers/35197461PubMed
34886361β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19).Int J Environ Res Public Health2021https://conductscience.org/library/papers/34886361PubMed
31144209Complement System: a Neglected Pathway in Immunotherapy.Clin Rev Allergy Immunol2020https://conductscience.org/library/papers/31144209PubMed
28710915Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.Transl Oncol2017https://conductscience.org/library/papers/28710915PubMed
24906530Complement in monoclonal antibody therapy of cancer.Immunol Res2014https://conductscience.org/library/papers/24906530PubMed
23474221Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab.Mol Oncol2013https://conductscience.org/library/papers/23474221PubMed
19515245The effects of beta-glucan on human immune and cancer cells.J Hematol Oncol2009https://conductscience.org/library/papers/19515245PubMed
16595791Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy.Clin Med Res2006https://conductscience.org/library/papers/16595791PubMed
9933447Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.Clin Exp Immunol1999https://conductscience.org/library/papers/9933447PubMed
8690804
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
J Clin Invest1996https://conductscience.org/library/papers/8690804PubMed
8485905CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.Clin Exp Immunol1993https://conductscience.org/library/papers/8485905PubMed
8306367
Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.
Cancer Immunol Immunother1994https://conductscience.org/library/papers/8306367PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
CRIPTO36998PubTator's text mininghttps://conductscience.org/library/genes/6998NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
ITGB23689PubTator's text mininghttps://conductscience.org/library/genes/3689NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1980339

GET https://conductscience.org/api/papers/v1/1980339/authors